✓ No active regulatory warningsFDA MedWatch, EMA EudraVigilance, WHO VigiBase, WADA Prohibited List · 2026-05-29
📰Read the full Turmeric / Curcumin evidence review on GMJ News →Complete clinical article, references and updates on news.gmj.ge. This page is the structured safety summary.⚠ Patient on multiple medications taking curcumin + piperine — piperine inhibits CYP3A4/CYP2C9, increasing drug levels [2]
⚠ Patient expecting turmeric latte to treat inflammation — needs bioenhanced supplement for systemic effects [2]
⚠ Patient on anticoagulants — curcumin has antiplatelet activity; additive bleeding risk [1]
⚠ Cancer patient relying on curcumin — no clinical trial evidence for cancer treatment [1]
ℹ️ Not obtained from food. A culinary spice rather than a nutrient with a daily target; curcumin content of food is low and variable.
🔬 Lab interpreter
Recommended test
No routine monitoring for curcumin supplementation
No routine monitoring for curcumin supplementation
Reference range / target
N/A
N/A
Monitor liver enzymes if taking high doses or if hepatotoxicity symptoms develop [1].
Full lab monitoring ↓⚕ For professionals — confirm ranges against your local laboratory.
Clinical verdict
Bioavailability is everything with curcumin — unformulated turmeric powder provides <1% absorption, making culinary use therapeutically irrelevant for systemic effects. Use bioenhanced formulations (Meriva, Theracurmin, or piperine combinations). Comparable to NSAIDs for OA pain in some trials. PIPERINE formulations inhibit CYP3A4 — major drug interaction concern for patients on medications [2] [3] [4].
1 How much do I need?
👤 Adults: Specific dosage data under clinical review
👴 Elderly: Specific dosage data under clinical review
🤰 Pregnancy: See guidance
Culinary turmeric is safe. Supplemental curcumin (high-dose, bioenhanced) has limited pregnancy safety data and possible uterotonic effects. Avoid supplementation without medical supervision [1].
👦 Pediatric: See guidance
Culinary turmeric is safe for children. Supplemental curcumin has limited pediatric data. Not routinely recommended without medical supervision [1].
🏃 Athletes: Standard dose
⚖️ Obesity: Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
🩺 Renal: Consult specialist
Dose adjustment may be needed in renal impairment.
🌱 Vegan: Standard dose
How to take
🍽 Timing: Take with food (fat improves absorption) [2].
💊 With food: Fat-containing meal enhances absorption of lipophilic curcumin [2].
2 Which form?
| Form | Bioavailability | Vegan | Cost |
|---|---|---|---|
| ['Curcumin + piperine (black pepper extract)', 'common', 'Piperine (BioPerine) increases curcumin bioavailability ~20-fold by inhibiting glucuronidation. Cheapest option. Piperine also affects drug metabolism (CYP3A4 inhibition) [2].'] | Standard | Check label | |
| ['Curcumin phytosome (Meriva)', 'preferred', 'Curcumin complexed with phosphatidylcholine. ~29× improved absorption vs unformulated curcumin. Well-studied in osteoarthritis trials [3].'] | Standard | Check label | |
| ['Nano-curcumin (Theracurmin, CurcuWIN)', '', 'Nanoparticle formulations with dramatically improved bioavailability (up to 2,000×). Smaller doses needed. More expensive [3].'] | Standard | Check label | |
| ['BCM-95 (Biocurcumax)', '', 'Turmeric essential oils + curcumin. ~6–7× improved bioavailability. Retains additional turmeric components [3].'] | Standard | Check label | |
| ['Unformulated curcumin/turmeric powder', '', 'Very poor absorption (<1%). Culinary use provides negligible systemic curcumin. Not suitable for therapeutic applications [2].'] | Standard | Check label |
3 Common questions
Why doesn't turmeric in food work like supplements? ▼
Turmeric powder is only 2–5% curcumin, and unformulated curcumin has <1% bioavailability. A teaspoon of turmeric delivers <1 mg of systemically absorbed curcumin — far below therapeutic levels [2]. Bioenhanced supplements (Meriva, Theracurmin, piperine combinations) increase absorption 20–2,000× [3].
Is curcumin as effective as NSAIDs for joint pain? ▼
Several RCTs have shown bioenhanced curcumin comparable to ibuprofen for osteoarthritis pain, with fewer GI side effects [4]. However, head-to-head comparisons are limited, and curcumin is slower to act (2–4 weeks). It is a reasonable alternative for mild-to-moderate OA pain.
Why does piperine matter? ▼
Piperine (from black pepper) inhibits hepatic and intestinal glucuronidation of curcumin, increasing bioavailability ~20-fold [2]. HOWEVER, piperine also inhibits CYP3A4 and CYP2C9, which metabolize many drugs. Patients on medications metabolized by these enzymes should use piperine-free curcumin formulations (Meriva, Theracurmin) [2].
Can curcumin cure cancer? ▼
Despite thousands of preclinical studies and enormous public interest, curcumin has NOT demonstrated anti-cancer efficacy in clinical trials [1]. The bioavailability problem makes systemic therapeutic levels nearly impossible to achieve. Some researchers have designated curcumin a 'PAINS' compound (pan-assay interference compound) — it interferes with many assay systems, potentially generating false-positive preclinical results [1].
4 Clinical evidence
Strong
In vitro and preclinical anti-inflammatory activity: curcumin inhibits NF-κB, COX-2, LOX-5, TNF-α, IL-1β, and IL-6 across hundreds of studies [1]. The bioavailability problem: unformulated curcumin achieves negligible plasma levels regardless of dose [2]. HIGH
Moderate
Osteoarthritis pain: meta-analysis of 8 RCTs showed curcumin (various formulations) significantly reduced pain and improved function, comparable to NSAIDs in some trials [4]. Ulcerative colitis (adjunctive): curcumin 1–3 g/day with mesalamine reduced relapse rates in an RCT [1]. Depressive symptoms: meta-analysis of 6 RCTs showed benefit of curcumin vs placebo [1]. Metabolic syndrome markers: modest improvements in fasting glucose, lipids, and inflammatory markers [1]. MODERATE
Insufficient
Cancer treatment or prevention: despite extensive preclinical data, clinical trials have not demonstrated benefit, largely due to bioavailability limitations [1]. Alzheimer disease: preclinical promise has not translated to clinical benefit [1]. COVID-19: some small trials with mixed results [1]. Curcumin as a standalone anti-inflammatory for RA: insufficient high-quality trials [1]. LOW
5 Safety, toxicity & adverse events
Absolute contraindications
✕ Active gallbladder disease/gallstones — curcumin stimulates bile secretion, may cause biliary colic
Relative
⚠ Concurrent anticoagulants (warfarin, DOACs) — curcumin inhibits platelet aggregation and may potentiate bleeding
⚠ Iron deficiency anemia — curcumin chelates iron, reducing absorption
⚠ Surgery — discontinue 2 weeks before due to antiplatelet effect
⚠ Concurrent chemotherapy — may interfere with some agents (discuss with oncologist)
⚠ Oxalate kidney stones — turmeric is high in soluble oxalates
🚩 Red flags
● Patient on warfarin + curcumin (especially with piperine) — additive bleeding + CYP inhibition [1] [2]
● New liver enzyme elevation in a turmeric supplement user — discontinue and investigate [1]
● Patient on narrow therapeutic index drugs (cyclosporine, tacrolimus) + piperine-containing curcumin — dangerous CYP3A4 inhibition [2]
6 Interactions
Drug interactions
CYP3A4/CYP2C9-metabolized drugs (via piperine) Major
Mechanism: PIPERINE (not curcumin itself) inhibits CYP3A4, CYP2C9, CYP2C19, and P-glycoprotein. This dramatically increases blood levels of drugs metabolized by these enzymes. [2]
Effect: Elevated blood levels of: statins, cyclosporine, tacrolimus, warfarin, phenytoin, theophylline, and many others. Potential toxicity. [2]
Action: For patients on medications: use piperine-FREE curcumin formulations (Meriva, Theracurmin). If using piperine, be aware of all CYP interactions [2].
Anticoagulants and antiplatelets Moderate
Mechanism: Curcumin inhibits platelet aggregation and thromboxane synthesis. [1]
Effect: Additive bleeding risk. [1]
Action: Monitor for bleeding symptoms. Use caution at doses >1 g/day curcuminoids with anticoagulants [1].
Supplement synergies
Boswellia (frankincense) · 300–500 mg boswellic acids/day
Curcumin + boswellia (5-LOX inhibitor) provides dual anti-inflammatory action. Meta-analysis supports the combination for OA [4].
Curcumin + boswellia (5-LOX inhibitor) provides dual anti-inflammatory action. Meta-analysis supports the combination for OA [4].
Omega-3 fatty acids · 1–2 g/day EPA+DHA
Complementary anti-inflammatory pathways. Curcumin (NF-κB) + EPA (resolvins) [1].
Complementary anti-inflammatory pathways. Curcumin (NF-κB) + EPA (resolvins) [1].
7 Regulatory
United States (FDA): Turmeric/curcumin classified as GRAS for food use and as a dietary supplement. No FDA-approved health claims. No drug approval [1].
European Union (EFSA): No authorized health claims for curcumin. Available as food supplement. EFSA established an ADI of 3 mg/kg body weight/day for curcumin as a food additive [1].
India (FSSAI): Turmeric is a traditional spice and Ayurvedic medicine. Widely used and regulated as food [1].
South Korea (MFDS): Registered health functional food ingredient. Approved claims: antioxidant activity.
8 US supplement products
9
on-market products containing Turmeric / Curcumin (NIH DSLD)
Brands carrying Turmeric / Curcumin (3)
Click a brand to see its Turmeric / Curcumin products.
9 Frequently paired with
10 Cite this page
Vancouver: Pkhakadze G. Turmeric / Curcumin — safety profile [Internet]. Tbilisi: PHIG; 2026 [cited 2026 Aug 07]. Available from: https://supplement.ge/ingredients/turmeric-curcumin/
APA 7th: Pkhakadze, G. (2026). Turmeric / Curcumin — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/turmeric-curcumin/
📋 Editorial information
Author: Prof. G. Pkhakadze, MD, MPH, PhD
Institution: Public Health Institute of Georgia (PHIG)
Affiliation: David Tvildiani Medical University (DTMU)
First published: January 2026
Last reviewed: 2026-05-29
Next review: February 2027
References: 4 cited sources
COI: SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
Process: Systematic literature review
📄 License & reuse
Published under Creative Commons Attribution 4.0 International (CC BY 4.0). You may share and adapt for any purpose with attribution.
Pkhakadze G. "Turmeric / Curcumin — Safety Profile." SupplementIndex, PHIG, 2026. https://supplement.ge/ingredients/turmeric-curcumin/ CC BY 4.0.
GP
Prof. G. Pkhakadze, MD, MPH, PhD
Professor of Public Health · Head of Department, DTMU
Editor-in-Chief, Georgian Medical Journal (ISSN 3088-4322)
Chair, Public Health Institute of Georgia · UEMS Public Health Section
Educational and public health purposes. CC BY 4.0. Consult your healthcare provider before starting any supplement. Corrections: info@accreditation.ge. Publisher: PHIG